Terms: = Pancreatic cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Prognosis
19 results:
1. DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and prognosis.
Gisder DM; Overheu O; Keller J; Nöpel-Dünnebacke S; Uhl W; Reinacher-Schick A; Tannapfel A; Tischoff I
Pathobiology; 2023; 90(2):71-80. PubMed ID: 35691289
[TBL] [Abstract] [Full Text] [Related]
2. Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts.
Li Z; Jia Y; Zhu H; Yuan H; Xing X; Xin Y; Ma T; Pang F; Zhang Y; Hu Y; Jia S; Ji J
Int J Cancer; 2022 Oct; 151(8):1382-1393. PubMed ID: 35567574
[TBL] [Abstract] [Full Text] [Related]
3. Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group.
Breton C; Meyer A; Malka D; Matias M; De Baere T; Hammel P; Sa Cunha A; Lucchese A; Fuks D; Coriat R; Gallois C; Touchefeu Y; Maillet M; Trouilloud I; Rompteaux P; Carbonnel F; Soularue E
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101607. PubMed ID: 33662776
[TBL] [Abstract] [Full Text] [Related]
4. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
[TBL] [Abstract] [Full Text] [Related]
5. Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature.
Hrudka J; Lawrie K; Waldauf P; Ciprová V; Moravcová J; Matěj R
Virchows Arch; 2020 Nov; 477(5):687-696. PubMed ID: 32424767
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of
Tran OT; Tadesse S; Chu C; Kidane D
Tumour Biol; 2020 May; 42(5):1010428320918404. PubMed ID: 32364878
[TBL] [Abstract] [Full Text] [Related]
7. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.
Ahmad-Nielsen SA; Bruun Nielsen MF; Mortensen MB; Detlefsen S
Pathol Res Pract; 2020 Jun; 216(6):152985. PubMed ID: 32360245
[TBL] [Abstract] [Full Text] [Related]
8. Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection.
Otsuka H; Murakami Y; Uemura K; Kondo N; Nakagawa N; Okada K; Seo S; Takahashi S
J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):421-428. PubMed ID: 32219999
[TBL] [Abstract] [Full Text] [Related]
9. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
Fraune C; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Amin T; Viol F; Fehrle W; Dum D; Höflmayer D; Burandt E; Clauditz TS; Perez D; Izbicki J; Wilczak W; Sauter G; Steurer S; Schrader J
Endocr Pathol; 2020 Jun; 31(2):182-189. PubMed ID: 32144630
[TBL] [Abstract] [Full Text] [Related]
10. Autoantibody-targeted TAAs in pancreatic cancer: A comprehensive analysis.
Zhou Y; Cui J; Du H
Pancreatology; 2019 Jul; 19(5):760-768. PubMed ID: 31255446
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of pancreatic cancer Patients Receiving Neoadjuvant Treatment.
Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
[TBL] [Abstract] [Full Text] [Related]
12. Epidemiology and risk factors of pancreatic cancer.
Capasso M; Franceschi M; Rodriguez-Castro KI; Crafa P; Cambiè G; Miraglia C; Barchi A; Nouvenne A; Leandro G; Meschi T; De' Angelis GL; Di Mario F
Acta Biomed; 2018 Dec; 89(9-S):141-146. PubMed ID: 30561407
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer.
Wang Y; Lin J; Cui J; Han T; Jiao F; Meng Z; Wang L
Oncotarget; 2017 Feb; 8(6):9354-9365. PubMed ID: 28030840
[TBL] [Abstract] [Full Text] [Related]
14. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.
Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S
Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415
[TBL] [Abstract] [Full Text] [Related]
15. Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only.
Ottenhof NA; Morsink FH; Ten Kate F; van Noorden CJ; Offerhaus GJ
Cell Oncol (Dordr); 2012 Apr; 35(2):119-26. PubMed ID: 22351431
[TBL] [Abstract] [Full Text] [Related]
16. [Chronic pancreatitis--pancreas cancer: influence of genetic factors].
Keim V
Praxis (Bern 1994); 2005 May; 94(20):811-7. PubMed ID: 15957615
[TBL] [Abstract] [Full Text] [Related]
17. Familial sarcoma: challenging pedigrees.
Lynch HT; Deters CA; Hogg D; Lynch JF; Kinarsky Y; Gatalica Z
Cancer; 2003 Nov; 98(9):1947-57. PubMed ID: 14584079
[TBL] [Abstract] [Full Text] [Related]
18. The clinical importance and prognostic implications of microsatellite instability in sporadic cancer.
Lawes DA; SenGupta S; Boulos PB
Eur J Surg Oncol; 2003 Apr; 29(3):201-12. PubMed ID: 12657227
[TBL] [Abstract] [Full Text] [Related]
19. Advances in molecular genetics.
Lairmore TC; Norton JA
Am J Surg; 1997 Jan; 173(1):37-41; discussion 42-3. PubMed ID: 9046882
[TBL] [Abstract] [Full Text] [Related]
